We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.01%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+62.01%
3 Year Est. Return
+164.15%
5 Year Est. Return
+274.12%
10 Year Est. Return
+2,470.02%
AUM
$1.11B
AUM Growth
+$52.8M
Cap. Flow
-$12.7M
Cap. Flow %
-1.14%
Top 10 Hldgs %
19.77%
Holding
2,152
New
581
Increased
526
Reduced
430
Closed
561

Sector Composition

Rank Sector Weight
1 Technology 16.1%
2 Healthcare 13.61%
3 Communication Services 11.16%
4 Consumer Discretionary 6.46%
5 Real Estate 6.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPGI icon
501
S&P Global
SPGI
$122B
$305K 0.03%
1,951
-1,054
-35% -$160K
AXS icon
502
AXIS Capital
AXS
$7.57B
$304K 0.03%
+5,310
New +$328K
VYX icon
503
NCR Voyix
VYX
$1.22B
$304K 0.03%
+13,203
New +$304K
MTOR
504
DELISTED
MERITOR, Inc.
MTOR
$304K 0.03%
+11,700
New +$232K
WAGE
505
DELISTED
WageWorks, Inc.
WAGE
$303K 0.03%
4,985
-100
-2% -$6.09K
PAHC icon
506
Phibro Animal Health
PAHC
$1.48B
$300K 0.03%
8,100
+4,200
+108% +$158K
PRU icon
507
Prudential Financial
PRU
$42.9B
$300K 0.03%
2,821
+591
+27% +$63.2K
CA
508
DELISTED
CA, Inc.
CA
$299K 0.03%
8,956
+8,195
+1,077% +$271K
JACK icon
509
CALL
Jack in the Box
JACK
$329M
$296K 0.03%
+2,900
New +$277K
WBKC
510
DELISTED
Wolverine Bancorp, Inc.
WBKC
$295K 0.03%
6,863
OXFD
511
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$294K 0.03%
17,482
-6,478
-27% -$105K
MITL
512
DELISTED
Mitel Networks Corporation
MITL
$293K 0.03%
34,961
+16,533
+90% +$131K
VRSN icon
513
VeriSign
VRSN
$27B
$289K 0.03%
2,714
+200
+8% +$20.1K
A icon
514
Agilent Technologies
A
$39.3B
$285K 0.03%
4,437
+3,432
+341% +$214K
KO icon
515
Coca-Cola
KO
$372B
$285K 0.03%
6,342
-1,069
-14% -$48.6K
HDS
516
DELISTED
HD Supply Holdings, Inc.
HDS
$285K 0.03%
7,900
-12,091
-60% -$389K
BOLD
517
DELISTED
Audentes Therapeutics, Inc
BOLD
$285K 0.03%
+10,180
New +$221K
LDR
518
DELISTED
Landauer Inc
LDR
$285K 0.03%
+4,234
New +$256K
ICE icon
519
Intercontinental Exchange
ICE
$83.8B
$284K 0.03%
+4,134
New +$272K
SNY icon
520
Sanofi
SNY
$102B
$283K 0.03%
+5,686
New +$275K
TRIP icon
521
TripAdvisor
TRIP
$1.67B
$283K 0.03%
+6,980
New +$284K
UTHR icon
522
United Therapeutics
UTHR
$22B
$282K 0.03%
+2,406
New +$307K
RVNC
523
DELISTED
Revance Therapeutics, Inc.
RVNC
$282K 0.03%
10,233
-5,892
-37% -$143K
AGIO icon
524
Agios Pharmaceuticals
AGIO
$1.89B
$281K 0.03%
4,215
+739
+21% +$44.4K
PARA
525
DELISTED
Paramount Global Class B
PARA
$281K 0.03%
+4,845
New +$306K

Similar funds

Prelude Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Prelude Capital Management held 2,152 positions worth $1.11B, up 5% from $1.06B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Prelude Capital Management's Q3 2017 filing shows 581 new, 526 increased, 430 reduced and 561 closed positions. Its largest new stake was Rockwell Collins: 63,879 shares worth $8.35M. The largest sale was Mobileye N.V., an estimated $25.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Communication Services.

  • Prelude Capital Management's largest Q3 2017 buy was Rockwell Collins: 63,879 shares worth $8.35M.
  • Prelude Capital Management added most to Calpine Corporation in Q3 2017, an estimated $12.6M increase.
  • Prelude Capital Management's biggest Q3 2017 reduction was Gray Television, cutting an estimated $14.3M.
  • Prelude Capital Management fully exited Mobileye N.V. in Q3 2017, selling an estimated $25.8M.
  • Prelude Capital Management's ten largest holdings make up 20% of its $1.11B portfolio in Q3 2017.
  • Prelude Capital Management opened 581 new positions and closed 561 in Q3 2017.
  • Prelude Capital Management's portfolio value rose 5% quarter-over-quarter to $1.11B.

Based on Prelude Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.